Domov › Akutna mieločna levkemija › Distrikta Columbia › Washington
Klinične študije za Akutna mieločna levkemija v Washington, DC
24 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Washington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Vključevanje udeležencevFaza 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- Center for Cancer and Blood Disorders, Bethesda · 7 mi stran
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Vključevanje udeležencevFaza 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Vključevanje udeležencevFaza 3
- MedStar Georgetown University Hospital, Washington D.C.
- Children's National Medical Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi stran
Longitudinal Studies of Patient With FPDMM
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Vključevanje udeležencevOpazovalna študija
- The Center for Cancer and Blood Disorders, Bethesda · 7 mi stran
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Vključevanje udeležencevFaza 1/2
- Children's National Medical Center, Washington D.C.
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Vključevanje udeležencevFaza 3
- Children's National - Main Hospital, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
Vključevanje udeležencevFaza 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Vključevanje udeležencevFaza 1
- Childrens National Medical Center, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Vključevanje udeležencevOpazovalna študija
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi stran
- Nih/Nhlbi, Bethesda · 7 mi stran
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Vključevanje udeležencevOpazovalna študija
- National Institutes of Health Clinical Center, Bethesda · 7 mi stran
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Vključevanje udeležencevFaza 1/2
- The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi stran
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Cancer Support Community Research & Training Institute, Washington D.C.
Massage Impact on Sleep in Pediatric Oncology
Vključevanje udeležencev
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Vključevanje udeležencevFaza 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Phase IB/II of CPX-351 for Relapse Prevention in AML
Vključevanje udeležencevFaza 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Študije za Akutna mieločna levkemija v drugih mestih
- Houston, TX85 študij
- New York City, NY51 študij
- Boston, MA44 študij
- Seattle, WA41 študij
- Baldwin Park, CA40 študij
- Columbus, OH35 študij
- Philadelphia, PA34 študij
- Durham, NC33 študij
- Atlanta, GA31 študij
- Tampa, FL29 študij
- Chicago, IL26 študij
- Portland, OR25 študij
Druge študije v Washington
- Rak (vse vrste)58 študij
- Nemalicelični pljučni rak55 študij
- Rak dojke46 študij
- Metastatski rak43 študij
- Rak pljuč41 študij
- Rak prostate38 študij
- Debelost33 študij
- Kolorektalni rak29 študij
- Srčno-žilne bolezni28 študij
- Rak mehurja26 študij
- Rak jajčnikov23 študij
- Limfom23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.